McKesson Corporation
MCK
주식 순위
#190
McKesson Corporation is a prominent global provider of healthcare services,... McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.
주가
$1,005.18
마지막 동기화: 2026-10-16
시가총액
$117.19B
변동 (1일)
0.83%
변동 (1년)
27.89%
국가
US
거래 McKesson Corporation (MCK)
카테고리
Healthcare
McKesson Corporation (MCK)의 영업이익률
October 2026 기준 영업이익률 TTM: 1.62%
McKesson Corporation의 최신 재무 보고서와 주가에 따르면 현재 영업이익률 (TTM)은 1.62%입니다. 2024년 말 기준 영업이익률은 1.27%였습니다.
McKesson Corporation의 영업이익률 기록 (2000 ~ 2026)
매년 말 영업이익률
| 연도 | 영업이익률 | 변화 |
|---|---|---|
| 2026 (TTM) | 1.62% | 32.79% |
| 2025 | 1.22% | -3.94% |
| 2024 | 1.27% | -21.12% |
| 2023 | 1.61% | 56.31% |
| 2022 | 1.03% | -29.93% |
| 2021 | 1.47% | 13.08% |
| 2020 | 1.30% | -9.72% |
| 2019 | 1.44% | 2.86% |
| 2018 | 1.40% | -17.16% |
| 2017 | 1.69% | -16.34% |
| 2016 | 2.02% | 2.54% |
| 2015 | 1.97% | 2.07% |
| 2014 | 1.93% | -2.53% |
| 2013 | 1.98% | 2.06% |
| 2012 | 1.94% | 3.74% |
| 2011 | 1.87% | 1.08% |
| 2010 | 1.85% | 14.91% |
| 2009 | 1.61% | 11.03% |
| 2008 | 1.45% | 5.07% |
| 2007 | 1.38% | 3.76% |
| 2006 | 1.33% | 6.40% |
| 2005 | 1.25% | -11.35% |
| 2004 | 1.41% | -13.50% |
| 2003 | 1.63% | 17.27% |
| 2002 | 1.39% | 504.35% |
| 2001 | 0.23% | -46.51% |
| 2000 | 0.43% | 0.00% |
유사 기업 또는 경쟁사의 영업이익률
| 회사 | 영업이익률 | 영업이익률 차이 | 국가 |
|---|---|---|---|
| 0.00% | - |
US
|
|
| 1.03% | -99.36% |
US
|
|
| 0.00% | - |
US
|
|
| 9.21% | -94.31% |
AU
|
|
| 5.69% | -96.49% |
US
|
회사의 영업이익률이란?
영업이익률은 회사의 수익성을 평가하는 핵심 지표입니다. 높은 영업이익률은 일반적으로 긍정적으로 간주되며, 이는 회사가 제품이나 서비스를 생산 비용보다 훨씬 높은 가격에 판매할 수 있음을 보여줍니다. 영업이익률은 회사의 수익을 매출로 나누어 계산합니다.